-
1
-
-
0024497294
-
Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva
-
Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96:147-166.
-
(1989)
Ophthalmology
, vol.96
, pp. 147-166
-
-
Jakobiec, F.A.1
Folberg, R.2
Iwamoto, T.3
-
2
-
-
0002027615
-
Response to Dr Folberg et al: Primary acquired melanosis of the conjunctiva in melanoma in situ
-
Ackerman AB. Response to Dr Folberg et al: primary acquired melanosis of the conjunctiva in melanoma in situ. Mod Pathol. 1992;5:6-8.
-
(1992)
Mod Pathol
, vol.5
, pp. 6-8
-
-
Ackerman, A.B.1
-
3
-
-
0023805184
-
Cryotherapy for conjunctival primary melanosis and malignant melanoma: Experience with 62 cases
-
Jakobiec FA, Rini FJ, Fraunfelder FT, Brownstein S. Cryotherapy for conjunctival primary melanosis and malignant melanoma: experience with 62 cases. Ophthalmology. 1988;95:1058-1069.
-
(1988)
Ophthalmology
, vol.95
, pp. 1058-1069
-
-
Jakobiec, F.A.1
Rini, F.J.2
Fraunfelder, F.T.3
Brownstein, S.4
-
5
-
-
0028009990
-
Pigmented conjunctival and scleral lesions
-
Liesegang TJ. Pigmented conjunctival and scleral lesions. Mayo Clin Proc. 1994;69:151-161.
-
(1994)
Mayo Clin Proc
, vol.69
, pp. 151-161
-
-
Liesegang, T.J.1
-
6
-
-
0003495105
-
-
Elmsford, NY: Pergamon Press Inc
-
Gilman AG, Rall TW, Nies AS, Taylor P, eds. Good-man and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. Elmsford, NY: Pergamon Press Inc; 1990;1247-1248.
-
(1990)
Good-man and Gilman's the Pharmacological Basis of Therapeutics. 8th Ed.
, pp. 1247-1248
-
-
Gilman, A.G.1
Rall, T.W.2
Nies, A.S.3
Taylor, P.4
-
8
-
-
0027952850
-
Mitomycin C therapy for corneal intraepithelial neoplasia
-
Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117;164-168.
-
(1994)
Am J Ophthalmol
, vol.117
, pp. 164-168
-
-
Frucht-Pery, J.1
Rozenman, Y.2
-
9
-
-
0028346006
-
The use of low-dose mitomycin C for prevention of recurrent pterygium
-
Frucht-Pery J, Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology. 1994;101:759-762.
-
(1994)
Ophthalmology
, vol.101
, pp. 759-762
-
-
Frucht-Pery, J.1
Ilsar, M.2
-
10
-
-
0027940092
-
Single dosage of mitomycin C for prevention of recurrent pterygium: Preliminary report
-
Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea. 1994;13: 411-413.
-
(1994)
Cornea
, vol.13
, pp. 411-413
-
-
Frucht-Pery, J.1
Ilsar, M.2
Hemo, I.3
-
11
-
-
0026496339
-
Serious complications of topical mitomycin C after pterygium surgery
-
Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992;99: 1647-1654.
-
(1992)
Ophthalmology
, vol.99
, pp. 1647-1654
-
-
Rubinfeld, R.S.1
Pfister, R.R.2
Stein, R.M.3
|